Pancreatic cancer Clinical Trials in Boise, ID
Boise, Idaho hosts paid clinical trials for Pancreatic cancer when studies are open for enrollment. Pancreatic cancer studies investigate new chemotherapy backbones, targeted inhibitors, and combination approaches to improve historically poor outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Boise
Filter results
0 clinical trials for Pancreatic cancer
·Clear filters·↓ Download CSVAbout research studies in Boise
Boise has approximately 233 recruiting research studies across a wide range of therapeutic areas. Idaho hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Boise
Researchers run research studies in Boise, ID at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Luke's Cancer Institute - Boise | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 88 |
| Saint Alphonsus Cancer Care Center-Boise | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Malignant Solid Neoplasm | 72 |
| Treasure Valley Medical Research | Atopic Dermatitis, Chronic Inducible Urticaria, Chronic Spontaneous Urticaria | 9 |
| St. Luke's Boise Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 7 |
| Boise VA Medical Center | Chronic Obstructive Pulmonary Disease, HIV, Inhaled Corticosteroid | 4 |
| Consultants in Epilepsy and Neurology, PLLC | Epilepsy, Focal Epilepsy, Focal Onset Seizure | 4 |
| Saint Alphonsus Regional Medical Center | Amyotrophic Lateral Sclerosis, RSV Infection | 4 |
| Advanced Specialty Research | Healthy, Idiopathic Overactive Bladder, Idiopathic Overactive Bladder With Urinary Incontinence | 3 |
| St. Luke's Cancer Institute | Colorectal Adenocarcinoma, KRAS G12C Lung Cancer, Multiple Myeloma | 3 |
| St. Luke's Cancer Institute: Boise | Carcinoma, Transitional Cell, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Neoplasm Metastasis | 3 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Boise VA Medical Center, Boise, ID | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Chronic Pain, Metastatic Castrate Resistant Prostate Cancer | 2 |
| CARE Institute - Boise Kidney | CKD, Kidney Disease, Metabolic Acidosis | 2 |
| Consultants in Epilepsy & Neurology, PLLC | Focal Epilepsy | 2 |
| Northwest Clinical Trials, Inc. | Actinic Keratosis, Migraine | 2 |
| Paradigm Clinical Research | Diabetes Mellitus, Type 1, Influenza | 2 |
| Saint Alphonsus Regional Medical Center - Boise | Atrial Fibrillation, Intracerebral Hemorrhage, Non-small Cell Lung Cancer | 2 |
| Saint Luke's Cystic Fibrosis Center of Idaho | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 2 |
| St. Alphonsus Regional Medical Center | Aortic Stenosis, Brain Tumor, Brain Tumor - Metastatic | 2 |
| St. Luke's Children's Endocrinology | Idiopathic Short Stature | 2 |
| St. Luke's Children's Endocrinology and Diabetes | Noonan Syndrome, Type 2 Diabetes | 2 |
| St. Lukes | Neuroblastoma | 2 |
| Asr, Llc | Alopecia Areata | 1 |
| Boise | Heart Failure With Preserved Ejection Fraction, Pulmonary Hypertension | 1 |
| Boise Kidney | FSGS | 1 |
Active & Upcoming Studies in Boise (2026)
Recruiting trials in Boise grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (113 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer · Phase 3 · Incyte Corporation
Neurology & pain (12 active studies)
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
- A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · Rapport Therapeutics Inc.
Cardiovascular (10 active studies)
- A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation · Boston Scientific Corporation
- Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System · Boston Scientific Corporation
Vaccines (6 active studies)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
Diabetes & metabolic (6 active studies)
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes · Phase 3 · Sanofi
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) · Phase 3 · Eli Lilly and Company
Mental health & behavior (3 active studies)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
- Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy · Phase 2 · Summit Hyperbarics and Wellness
HIV / STI (1 active study)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
Common conditions studied in Boise
- Acute Myeloid Leukemia (8 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- ARDS (5 active studies). Recruiting ARDS studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Respiratory Distress Syndrome (5 active studies). Recruiting Acute Respiratory Distress Syndrome studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IIIB Lung Cancer AJCC v8 (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Stage IV Lung Cancer AJCC v8 (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Boise
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Local regulations and guidelines
Clinical trials in Idaho are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Idaho research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Boise. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Boise
Hipa.ai aggregates every recruiting study in Boise from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Boise?
There are approximately 233 recruiting clinical trials in Boise, Idaho listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Boise pay participants?
Most recruiting trials in Boise compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Boise?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Boise?
The most common conditions under active study in Boise include Acute Myeloid Leukemia (8), ARDS (5), Acute Respiratory Distress Syndrome (5), Malignant Solid Neoplasm (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Boise?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Boise on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Boise?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Boise?
Recruiting research sites in Boise include Saint Luke's Cancer Institute - Boise, Saint Alphonsus Cancer Care Center-Boise, Treasure Valley Medical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Boise right now?
The largest active categories in Boise are Cancer & tumors (113), Neurology & pain (12), Cardiovascular (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.